These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29101671)

  • 21. Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer's Disease: A PET Study.
    Planton M; Saint-Aubert L; Raposo N; Payoux P; Salabert AS; Albucher JF; Olivot JM; Péran P; Pariente J
    J Alzheimers Dis; 2020; 73(4):1607-1614. PubMed ID: 31958082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular imaging of misfolded protein pathology for early clues to involvement of the heart.
    Merlini G; Narula J; Arbustini E
    Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1649-51. PubMed ID: 24990402
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel imaging techniques using
    Shouman K; Broski SM; Muchtar E; Pendleton CA; Johnson GB; Tracy J; Engelstad JK; Spinner RJ; Dyck PJB
    Muscle Nerve; 2021 Jan; 63(1):104-108. PubMed ID: 33094511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Semiautomated Method for Quantification of F 18 Florbetapir PET Images.
    Joshi AD; Pontecorvo MJ; Lu M; Skovronsky DM; Mintun MA; Devous MD
    J Nucl Med; 2015 Nov; 56(11):1736-41. PubMed ID: 26338898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 18F-Florbetapir PET in Primary Cerebral Amyloidoma.
    Soffers F; Ceyssens S; Buffet W; de Surgeloose D; Crols R
    Clin Nucl Med; 2020 Oct; 45(10):838-839. PubMed ID: 32796236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is in vivo amyloid distribution asymmetric in primary progressive aphasia?
    Martersteck A; Murphy C; Rademaker A; Wieneke C; Weintraub S; Chen K; Mesulam MM; Rogalski E;
    Ann Neurol; 2016 Mar; 79(3):496-501. PubMed ID: 26600088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging.
    Chiotis K; Carter SF; Farid K; Savitcheva I; Nordberg A;
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1492-506. PubMed ID: 26130168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A consecutive case series experience with [18 F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition.
    Mitsis EM; Bender HA; Kostakoglu L; Machac J; Martin J; Woehr JL; Sewell MC; Aloysi A; Goldstein MA; Li C; Sano M; Gandy S
    Mol Neurodegener; 2014 Feb; 9():10. PubMed ID: 24484858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survival.
    Dubrey S; Simms RW; Skinner M; Falk RH
    Am J Cardiol; 1995 Oct; 76(10):739-41. PubMed ID: 7572642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent cardiac amyloidosis following previous heart transplantation.
    Luk A; Ahn E; Lee A; Ross HJ; Butany J
    Cardiovasc Pathol; 2010; 19(4):e129-33. PubMed ID: 19740680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of amyloid deposits by (18)F-florbetapir positron emission tomography.
    Martínez-Valle F; Gironella M; Riveiro-Barciela M; Lorenzo-Bosquet C
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1778-1779. PubMed ID: 26081942
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantification of [
    Golla SS; Verfaillie SC; Boellaard R; Adriaanse SM; Zwan MD; Schuit RC; Timmers T; Groot C; Schober P; Scheltens P; van der Flier WM; Windhorst AD; van Berckel BN; Lammertsma AA
    J Cereb Blood Flow Metab; 2019 Nov; 39(11):2172-2180. PubMed ID: 29897009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Florbetapir F 18 for brain imaging of β-amyloid plaques.
    Romano M; Buratti E
    Drugs Today (Barc); 2013 Mar; 49(3):181-93. PubMed ID: 23527322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pittsburgh B Compound Positron Emission Tomography in Patients With AL Cardiac Amyloidosis.
    Lee SP; Suh HY; Park S; Oh S; Kwak SG; Kim HM; Koh Y; Park JB; Kim HK; Cho HJ; Kim YJ; Kim I; Yoon SS; Seo JW; Paeng JC; Sohn DW
    J Am Coll Cardiol; 2020 Feb; 75(4):380-390. PubMed ID: 32000949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal Target Region for Subject Classification on the Basis of Amyloid PET Images.
    Carbonell F; Zijdenbos AP; Charil A; Grand'Maison M; Bedell BJ;
    J Nucl Med; 2015 Sep; 56(9):1351-8. PubMed ID: 26135108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis.
    Lilleker JB; Hodgson R; Roberts M; Herholz K; Howard J; Hinz R; Chinoy H
    Ann Rheum Dis; 2019 May; 78(5):657-662. PubMed ID: 30760470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tc-99m(V) DMSA uptake in cardiac amyloidosis.
    Ohta H; Okada T; Furukawa Y; Yamamoto K; Miyaki Y; Shizuki K; Kotoura H; Endo K; Konishi J; Ohshima C
    Clin Nucl Med; 1991 Sep; 16(9):673-5. PubMed ID: 1657486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging cardiac amyloidosis: an opportunity for nuclear cardiology.
    Dorbala S
    J Nucl Cardiol; 2014 Dec; 21(6):1043-4. PubMed ID: 25367453
    [No Abstract]   [Full Text] [Related]  

  • 39. 18 F-Flutemetamol PET/CT for Transthyretin Amyloid Cardiomyopathy : Timing Matters.
    Han EJ; Sung YE; Jung MH; O JH; Youn JC
    Clin Nucl Med; 2022 Dec; 47(12):1074-1076. PubMed ID: 36240762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autonomic Cardiac Function in Preclinical Alzheimer's Disease.
    Santos CY; Machan JT; Wu WC; Snyder PJ
    J Alzheimers Dis; 2017; 59(3):1057-1065. PubMed ID: 28697563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.